Brain natriuretic peptide and left ventricular dysfunction in chagasic cardiomyopathy

Memorias do Instituto Oswaldo Cruz

Volumn 99, Issue 6, 2004, Pages 645-649

  Talvani, Andre ^a,c   Rocha, Manoel O C ^a   Cogan, John ^b   Maewal, Param ^b   De Lemos, James ^b   Ribeiro, Antonio L P ^a   Teixeira, Mauro M ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c PONTIFICAL CATHOLIC UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Brain natriuretic peptide; Chagas disease; Chagasic cardiomyopathy; Left ventricular dysfunction

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE;

ADULT; ARTICLE; CHAGAS DISEASE; CLINICAL EXAMINATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE MARKER; ECHOCARDIOGRAPHY; ENDEMIC DISEASE; FEMALE; HEART LEFT VENTRICLE FAILURE; HORMONE ACTION; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 7744227809     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02762004000600020     Document Type: Article

References (25)

1. Barros MV, Ribeiro AL, Machado FS, Rocha MOC 2003. Doppler tissue imaging to assess systolic function in Chagas disease. Arq Bras Cardiol 80: 36-40.
2. Bestetti RB 2001. Predictors of unfavourable prognosis in chronic Chagas' disease. Trop Med Int Health 6: 476-483.
3. Carrasco HA, Parada H, Guerrero L, Duque M, Duran D, Molina C 1994. Prognostic implications of clinical, electrocardiographic and hemodynamic findings in chronic Chagas' disease. Int J Cardiol 43: 27-38.
4. Cheng V, Kazanegra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N, Clopton, P, Maisel A 2001. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted for decompensated heart failure. A pilot study. J Am Coll Cardiol 37: 386-391.
5. Clerico A, Del Ry S, Giannessi D 2000. Measurement of cardiac natriuretic hormones (atrial natriuretic peptide, brain natriuretic peptide and related peptides) in clinical practice: the need for a new generation of immunoassay methods. Clin Chem 46: 529-534.
6. Dao Q, Krishmaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, Clopton P, Alberto J, Hlavin P, Maisel AS 2001. Utilily of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 37: 370-385.
7. de Lemos JA, McGuire DK, Drazner MH 2003. B-type Natriuretic Peptide (BNP) in cardiovascular disease. Lancet 362: 316-322.
8. de Lemos JA, Morrow DA, Bentley JH, Omland T, Sabatine MS, McCabe CH, Hall C, Cannon CP, Braunwald E 2001. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Eng J Med 345: 1014-1021.
9. Deo R, De Lemos JA 2003. B-type natriuretic peptide in ischemic heart disease. Curr Cardiol Rep 5: 271-277.
10. Kuster GM, Tanner H, Printzen G, Suter TM, Mohacsi P, Hess OM 2003. B-type natriuretic peptide for diagnosis and treatment of congestive heart failure. Swiss Med Wkly 133: 623-628.
11. Mady C, Cardoso RHA, Barreto ACP, da Luz PL, Bellotti G, Pileggi F 1994. Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation 90: 3098-3102.
12. Maeda K, Takayoshi T, Wada A, Hisanaga T, Kinoshita M 1998. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 135: 825-832.
13. Maguire JH, Hoff R, Sherlock I, Guimaraes AC, Sleigh AC, Ramos NB, Mott KE, Weller TH 1987. Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community. Circulation 75: 1140-1145.
14. Maisel A, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen, CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA 2002. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347: 161-167.
15. McCullough PA, Nowak RM, McCord J, Hollander JE, Herrmann HC, Steg PG, Duc P, Westheim A, Omland T, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS 2002. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure. Circulation 106: 416-422.
16. Nakagawa O, Ogawa Y, Itoh H 1995. Rapid transcriptional activation and early mRNA turnover of BNP in cardiocyte hypertrophy: evidence for BNP as an emergency cardiac hormone against ventricular overload. J Clin Invest 96: 1280-1287.
17. Perez AA, Ribeiro AL, Barros MV, de Sousa MR, Bittencourt RJ, Machado FS, Rocha MO 2003. Value of the radiological study of the thorax for diagnosing left ventricular dysfunction in Chagas' disease. Arq Bras Cardiol 80: 208-213.
18. Prata A 2001. Clinical and epidemiological aspects of Chagas disease. The Lancet 1: 92-100.
19. Rassi Jr A, Rassi A, Little WC 2000. Chagas' heart disease. Clin Cardiol 23: 883-889.
20. Ribeiro AL, Lombardi F, Sousa MR, Barros MV, Porta A, Costa VB, Gomes ME, Santana MF, Rocha MOC 2002a. Power-law behavior of heart rate variability in Chagas' disease. Am J Cardiol 89: 414-418.
21. Ribeiro ALP, Reis AM, Barros MV, Sousa MR, Rocha ALL, Perez AA, Pereira JB, Machado FS, Rocha MOC 2002b. Brain natriuretic peptide in the diagnosis of systolic left ventricular dysfunction in Chagas disease. Lancet 360: 461-462.
22. Ribeiro AL, Reis AM, Teixeira MM, Rocha MOC 2003. Brain natriuretic peptide in Chagas disease: further insights. Lancet 362: 333.
23. Rocha MOC, Ribeiro AL, Teixeira MM 2003. Clinical Managemente of chronic Chagas cardiomyopathy. In Cap. Chagas heart disease. Front Biosc 8: E44-54.
24. Silberbach M, Roberts CT 2001. Natriuretic peptide signaling molecular and cellular pathways to growth regulation. Cellular Signalling 13: 221-231.
25. Villacorta H, Duarte A, Duarte NM, Carrano A, Mesquista ET, Dohmann HJ, Ferreira FE 2002. The role of B-type natriuretic peptide in the diagnosis of congestive heart failure in patients presenting to an emergency department with dyspnea. Arq Bras Cardiol 79: 569-572.